8 recruiting, 8 unknown, 5 completed, 5 terminated. 10 Phase 1, 6 Not applicable, 5 Phase 2, 2 Early Phase 1, 2 Phase 4.
Follow Metastatic Liver Cancer: new trials by email Literature Review of Metastatic Liver Cancer trials Research Report on Metastatic Liver Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) Lu-PSMA-617 - Liver Cancer, Hepatocellular Carcinoma | Phase 2 | Recruiting | Melissa Lumish | 10 | 2026-06-01 | 2026-05-08 |
| Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC EB-G3B7-NK dual-target CAR-NK cells, Fludarabine, Cyclophosphamide - Advanced Hepatocellular Carcinoma (HCC), Metastatic Liver Cancer | Phase 1 / Phase 2 | Recruiting | Beijing Biotech | 30 | 2026-03-02 | 2026-03-30 |
| Streamlining Radioembolization for CCC and Metastatic Liver Cancer Metastatic Colorectal Carcinoma (mCRC), Metastatic Liver Cancer | Recruiting | Seoul National University Hospital | 60 | 2025-06-22 | 2026-08-18 | |
| A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors ERX-315 - Advanced Solid Tumor, Metastatic Breast Cancer | Phase 1 | Recruiting | EtiraRx Australia Pty Ltd | 36 | 2024-10-14 | 2026-05-29 |
| Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures BioTraceIO 360 - Hepatocellular Carcinoma, Metastatic Liver Cancer | Not applicable | Terminated | Techsomed Medical Technologies LTD | 4 | 2023-09-05 | 2025-09-15 |
| Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree Primary Liver Cancer, Metastatic Liver Cancer | Unknown | Beijing Tsinghua Chang Gung Hospital | 820 | 2023-08-01 | 2023-08-14 | |
| Safety and Effectiveness of BioTraceIO 360 for Planning, Monitoring and Assessment of Liver Tissue Ablation Procedures (PANORAMA2) BioTraceIO 360 - Hepatocellular Carcinoma, Metastatic Liver Cancer | Not applicable | Withdrawn | Techsomed Medical Technologies LTD | 2023-07-01 | 2023-11-27 | |
| PDO/PDO-TIL/PDOTS for Drug Screen Drug screen with PDO/PDO-TIL/PDOTS - Liver Cancer, Metastatic Liver Cancer | Unknown | Shanghai Zhongshan Hospital | 30 | 2023-06-01 | 2023-06-22 | |
| Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy HAIC、Bevacizumab、Camrelizumab - Metastatic Liver Cancer | Phase 1 | Unknown | Fudan University | 80 | 2022-12-01 | 2022-12-08 |
| Anti-CEA CAR-T Cells to Treat Colorectal Liver Metastases Anti-CEA CAR-T Cells - Colorectal Cancer, Metastatic Liver Cancer | Phase 1 | Recruiting | Changhai Hospital | 18 | 2022-08-25 | 2022-03-11 |
| ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma ET140203 T Cells - Hepatoblastoma, Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | Recruiting | Eureka Therapeutics Inc. | 12 | 2022-07-19 | 2026-07-06 |
| Liver Transplantation for Unresectable GIST Liver Metastases Liver Transplantation - Liver Diseases, Liver Cancer | Not applicable | Unknown | Hospital Universitario Virgen de la Arrixaca | 50 | 2022-05-01 | 2022-03-11 |
| GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC ECT204 T cells - Hepatocellular Carcinoma, Liver Cancer, Adult | Phase 1 / Phase 2 | Recruiting | Eureka Therapeutics Inc. | 60 | 2022-03-11 | 2026-09-10 |
| Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures BioTraceIO Lite - Carcinoma, Hepatocellular, Metastatic Liver Cancer | Completed | Techsomed Medical Technologies LTD | 65 | 2021-09-24 | 2023-04-18 | |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Liver transplantation - Colorectal Cancer, Metastatic Liver Cancer | Recruiting | Hospital Universitario La Fe | 30 | 2021-09-01 | 2023-09-22 | |
| Study of ET140203 T Cells in Adults With Advanced Hepatocellular Carcinoma (ARYA-1) ET140203 autologous T cell product - Hepatocellular Carcinoma, Liver Cancer | Phase 1 | Terminated | Eureka Therapeutics Inc. | 8 | 2021-04-14 | 2025-09-08 |
| DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria Extra DCE-CT scan - Cancer, Lung, Perfusion Computed Tomography Target Lesion | Not applicable | Unknown | Hyperfusion | 100 | 2021-01-07 | 2021-02-09 |
| Study of ET140202 T Cells in Adults With Advanced Hepatocellular Carcinoma ET140202 autologous T cell product - Hepatocellular Carcinoma, Liver Cancer | Phase 1 | Terminated | Eureka Therapeutics Inc. | 2 | 2019-05-30 | 2022-08-23 |
| ET 140202 -T Cell Combined With TAE or Sorafenib in the Treatment of Liver Cancer Sorafenib combined with ET140202-T cell, TAE combined with ET140202-T cell, ET140202-T cell - Hepatocellular Carcinoma, Liver Cancer | Early Phase 1 | Unknown | First Affiliated Hospital Xi'an Jiaotong University | 27 | 2019-05-30 | 2019-08-08 |
| ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma ET1402L1-ARTEMIS™ T cells -IV, ET1402L1-ARTEMIS™ T cells -intra-hepatic artery, ET1402L1-ARTEMIS™ T cells -Intratumoral Injections - Hepatocellular Carcinoma, Liver Cancer | Early Phase 1 | Completed | First Affiliated Hospital Xi'an Jiaotong University | 12 | 2017-12-06 | 2021-03-29 |
Showing 20 of 31. Sign in to see all of them.
Liver Neoplasms (31) · Carcinoma, Hepatocellular (16) · Colorectal Neoplasms (5) · Neoplasm Metastasis (4) · Cholangiocarcinoma (3) · Breast Neoplasms (1) · Echinococcosis, Hepatic (1) · Endometrial Neoplasms (1) · Gastrointestinal Stromal Tumors (1) · Hepatoblastoma (1) · Liver Diseases (1) · Lung Neoplasms (1) · Melanoma (1) · Nausea (1) · Ovarian Neoplasms (1)
Digestive System Diseases (31) · Digestive System Neoplasms (31) · Neoplasms (31) · Neoplasms by Site (31) · Liver Diseases (30) · Neoplasms by Histologic Type (19) · Adenocarcinoma (18) · Carcinoma (18) · Neoplasms, Glandular and Epithelial (18) · Gastrointestinal Diseases (6) · Gastrointestinal Neoplasms (6) · Colonic Diseases (5) · Intestinal Diseases (5) · Intestinal Neoplasms (5) · Pathological Conditions, Signs and Symptoms (5)
Electroporation (2) · Liver Transplantation (2) · Capecitabine (1) · Chemotherapy, Adjuvant (1) · Cyclophosphamide (1) · Drug Evaluation (1) · Drug Therapy (1) · Hepatectomy (1) · Melphalan (1) · Neoadjuvant Therapy (1) · Pluvicto (1) · Radiofrequency Ablation (1) · Radionuclide Generators (1) · Sirtuins (1) · Tropisetron (1)
Eureka Therapeutics Inc. (4) · Techsomed Medical Technologies LTD (3) · First Affiliated Hospital Xi'an Jiaotong University (2) · Fudan University (2) · Aeon Therapeutics (Shanghai) Co., Ltd. (1) · Asan Medical Center (1) · Azienda Ospedaliera di Padova (1) · Beijing Biotech (1) · Beijing Tsinghua Chang Gung Hospital (1) · Boston Scientific Corporation (1) · Changhai Hospital (1) · Delcath Systems Inc. (1) · EtiraRx Australia Pty Ltd (1) · Fox Chase Cancer Center (1) · Fundación de Investigación Biomédica - Hospital Universitario de La Princesa (1)
United States (11) · China (8) · Spain (3) · South Korea (2) · Australia (1) · Belgium (1) · Canada (1) · France (1) · Italy (1) · Taiwan (1) · United Kingdom (1)
Pei Wang, PhD (3) · Alejandro Mejia, MD (1) · Alessandro Vitale, MD (1) · Chang Liu, PhD (1) · Charles W Nutting, DO (1) · Derek L West, MD (1) · Eric D Whitman, MD (1) · H. Richard Alexander, MD (1) · James F Pingpank, MD (1) · Jonathan Zager, MD (1) · Kyung Won Kim, M.D. (1) · Lu Wang (1) · Mark Faries, MD (1) · Melissa Lumish, MD (1)